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0022-2836 © 2008 Elsevier Ltd. Open accThioredoxin functions in nearly all organisms as the major thiol–disulfide
oxidoreductase within the cytosol. Its prime purpose is to maintain cysteine-
containing proteins in the reduced state by converting intramolecular
disulfide bonds into dithiols in a disulfide exchange reaction. Thioredoxin
has been reported to contribute to a wide variety of physiological functions
by interacting with specific sets of substrates in different cell types. To
investigate the function of the essential thioredoxin A (TrxA) in the low-GC
Gram-positive bacterium Bacillus subtilis, we purified wild-type TrxA and
three mutant TrxA proteins that lack either one or both of the two cysteine
residues in the CxxC active site. The pure proteins were used for substrate-
binding studies known as “mixed disulfide fishing” in which covalent
disulfide-bonded reaction intermediates can be visualized. An unprece-
dented finding is that both active-site cysteine residues can form mixed
disulfides with substrate proteins when the other active-site cysteine is
absent, but only the N-terminal active-site cysteine forms stable interac-
tions. A second novelty is that both single-cysteine mutant TrxA proteins
form stable homodimers due to thiol oxidation of the remaining active-site
cysteine residue. To investigate whether these dimers resemble mixed
enzyme–substrate disulfides, the structure of the most abundant dimer,
C32S, was characterized by X-ray crystallography. This yielded a high-
resolution (1.5Å) X-ray crystallographic structure of a thioredoxin homo-
dimer from a low-GC Gram-positive bacterium. The C32S TrxA dimer can
be regarded as a mixed disulfide reaction intermediate of thioredoxin,
which reveals the diversity of thioredoxin/substrate-binding modes.© 2008 Elsevier Ltd. Open access under CC BY license.Edited by R. Hubber Keywords: disulfide; thioredoxin; Bacillus; structure; dimeress:
equally to this work.
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Thioredoxin is a ubiquitous protein that is present
in nearly all known organisms from archaea to hu-
mans.1 It is a ∼ 12-kDa soluble protein with a char-
acteristic thioredoxin fold, which is active in the
cytosol. Its prime purpose is to maintain cysteine-
containing proteins in the reduced state by convert-
ing intramolecular disulfide bonds into dithiols.
Thioredoxin thus has an important thiol–disulfide
oxidoreductase function in the cell, and this is the
main reason that this enzyme has been studied ex-
tensively since it was first described in 1964.2
Additionally, it has been proposed that thioredoxins
521Dimer Structure of C32S Mutant Bacillus TrxAhave chaperone activity in protein folding.3 The
majority of these studies have been conducted on
Escherichia coli thioredoxin A (TrxA) and human
thioredoxin 1. The latter enzyme, hereinafter referred
to as Trx1, has a role in the regulation of cell proli-
feration and differentiation and in programmed cell
death. Hence, it is a key target for the development of
drugs to treat cancer, especially since increased
thioredoxin levels are seen in many human primary
cancers.4 In plant chloroplasts, thioredoxin regulates
the light-activated Calvin cycle;5 in E. coli, thior-
edoxin plays a critical role in cellular responses to
oxidative stress.6 In general, the specific physiologi-
cal roles of thioredoxins in different organisms are
directly related to the specific functions of their
substrates in these organisms.
In its active site, thioredoxin has two cysteine
residues in a conserved amino acid motif Trp-Cys-
Gly-Pro-Cys, which is a defining characteristic of
thioredoxins.7 The generally believedmode of action
of thioredoxins is as follows.8–10 An oxidized
disulfide-containing substrate protein will bind to a
conserved hydrophobic surface of the thioredoxin. In
the active form, the catalytic cysteines of thioredoxin
are reduced. Importantly, the lower pKa value of the
N-terminal cysteine of thioredoxin promotes its
existence as a thiolate, the reactive deprotonated
form of thiol, and this thiolate can act as a nucleo-
phile to combine with a protein substrate, resulting
in a covalently linked mixed disulfide (thioredoxin–
S–S–protein). The close proximity (i.e., high local
concentration) of the thiol group of the second C-
terminal cysteine in the thioredoxin active site faci-
litates the next step of the reaction where the fully
reduced protein and the disulfide-containing thio-
redoxin are generated. Oxidized thioredoxin is
then reduced back to its active form by thioredoxin
reductase.11
The three-dimensional structures of many thio-
redoxin variants have been determined to visualize
the protein states during specific stages of the thio-
redoxin catalytic cycle. The structure of the wild-
type Bacillus subtilis TrxA (BsTrxA) was originally
solved by NMR as a monomer in the oxidized and
reduced states.12 The structure of the BsTrxA C32S
mutant was solved by NMR as a heterodimer com-
plex with the substrate protein, arsenate reductase
(ArsC).12 In addition, there are structures for un-
complexed human Trx1, which has been structurally
characterized in both its reduced state and its
oxidized state by X-ray crystallography,13 and with
bound peptides from substrate proteins by NMR.14,15
There is also a structure for the plant thioredoxin/
substrate complex between barley thioredoxin and
α-amylase/subtilisin inhibitor [barley α-amylase/
subtilisin inhibitor (BASI)].16 The E. coli thioredoxins
have similarly been structurally characterized in
detail.17,18 Several other uncomplexed thioredoxin
structures, from humans, E. coli, and other sources,
are available in the Protein Data Bank (PDB; sum-
marized in Maeda et al.16). The interaction between
thioredoxin and thioredoxin reductase, the enzyme
that reduces thioredoxin to restore it to its activestate, has been visualized in structures of the com-
plexes between the E. coli thioredoxin reductase and
thioredoxin,19 and also between ferrodoxin–thior-
edoxin reductase and spinach chloroplast thioredox-
ins (Trx-f and Trx-m).20 In addition, there is a 2.2-Å
crystal structure of thioredoxin in complex with
DNA polymerase from bacteriophage T7.21 In this
study, however, thioredoxin forms a stable complex
involved in the processivity of DNA replication for
which its redox function is not required. The wealth
of available structures allows comparison of com-
plex structures from which more general informa-
tion can be derived.
In contrast to its counterparts from humans, plant
chloroplasts, and Gram-negative bacteria such as
E. coli, relatively little is known about the TrxA of
Gram-positive bacteria such as B. subtilis. It has been
shown that the trxA gene is essential for the growth
and viability of B. subtilis, and its expression at
elevated levels is triggered by multiple stresses.22,23
Furthermore, TrxA limitation represents a form of
stress that impacts on a wide range of physiologi-
cally and developmentally important processes in
B. subtilis, such as the development of competence
for DNA binding and uptake.24 The essentiality of
trxA in B. subtilis underpins a remarkable biological
difference from the situation in E. coliwhere the two
genes for thioredoxins (trxA and trxC) are not
essential.25 Most likely, this difference relates to the
absence of glutathione from B. subtilis26 and the
presence of this reducing agent in E. coli.11,27 This
difference focuses interest on the substrates of TrxA
in B. subtilis, some of which will be essential for
growth and viability, as argued above. A highly
elegant technique, named mixed disulfide fishing,
has been employed to identify thioredoxin/sub-
strate in various biological systems.28,29 In essence,
the second C-terminal cysteine in the thioredoxin
active site is replaced with serine. The resulting
mutant thioredoxin is still able to bind its substrates
via the N-terminal (attacking) cysteine, but the
subsequent release of a reduced substrate is pre-
cluded by the absence of the C-terminal (resolving)
cysteine. Consequently, normally very short-lived
covalent enzyme–substrate reaction intermediates
accumulate, which can then be purified and ana-
lyzed to identify the bound substrates.
In the present study, we have established the tools
for mixed disulfide fishing in B. subtilis, including
highly purified active-site mutant BsTrxA proteins
(i.e., C29S and C32S single and double mutants) and
a wild-type TrxA control. Our special attention was
focused on the characterization of the single-cysteine
mutant proteins because both mutant proteins
displayed a so far uncharacterized auto-oxidation
that resulted in homodimer formation under non-
reducing conditions. Consistent with our findings,
early studies by Chandrasekhar et al., Dyson et al.,
Jeng et al., and Russel et al. on thioredoxins of E. coli
mention that DTT-reducible dimers can be formed by
active-site mutant proteins lacking the resolving
cysteine, but the respective observations were not
documented in detail.30–33 Furthermore, the homo-
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lacking the attacking cysteine was unprecedented.
To define the molecular basis of these observations,
we set out to characterize the three-dimensional
structure of the C32S BsTrxA homodimer by X-ray
crystallography. Here we present the first structure
of a BsTrxA C32S homodimer at 1.5 Å resolution.
Comparison of this structure with the NMR struc-
ture of the BsTrxA complexedwith a substrate, ArsC,
shows two distinct modes of substrate binding in
which the peptide chains are bound in different
orientations. There is a conserved hydrophobic
pocket on one side of the catalytic N-terminal cys-
teine, which binds a large hydrophobic residue in
many thioredoxin structures.Results
Mixed disulfide fishing
As a first approach to developing the tools for
mixed disulfide fishing of potential substrates ofFig. 1. Mixed disulfide fishing. Mixed disulfide fishing was
the wild-type active site or with active-site-specific mutations, a
WB800 ItrxA strain. (a) To show that the BsTrxA proteins used
BsTrxA protein variant was loaded on SDS-PAGE. Upon elec
wild-type active site; C29S, C29S single-mutant BsTrxA; C3
double-mutant BsTrxA. (b) To visualize possible stable inter
BsTrxA protein variant was mixed with 50 μl of cytoplasmic
separated on a nonreducing gel, and BsTrxA–substrate compl
raised against B. subtilis TrxA. Background: The cytoplasmic
protein reveals a few nonspecific cross-reactions of the BsT
substrate complexes. For purification of the BsTrxA–substrat
BsTrxA proteins was used. Pure BsTrxAwith the wild type or
extracts as indicated for (b). Subsequently, magnetic beads pr
BsTrxA proteins was allowed to bind to the nickel of the magne
beads with bound BsTrxA. After the beads had been washed n
with a buffer containing imidazole. The eluted proteins were
substrate bound complexes were visualized by Western blottiBsTrxA, we introduced single-cysteine mutations
(i.e., C29S or C32S) or a double-cysteine mutation
(C29S–C32S) into this protein. In addition, wild-type
BsTrxA and the three cysteine-mutant derivatives
were provided with a C-terminal His6-tag, allowing
their successful purification to ∼1mg/ml by Ni-
affinity chromatography. A silver-stained SDS-poly
acryl amide gel of these purified proteins shows that
the respective samples did not contain any detect-
able impurities (Fig. 1a), and this was confirmed by
mass spectrometry (data not shown). Next we tested
whether these four purified proteins would bind to
cytoplasmic proteins of a B. subtilis strain that was
depleted for TrxA. The rationale behind this experi-
ment was that potential oxidized TrxA substrate
proteins would be present at elevated levels in a
strain depleted for TrxA. To probe their interaction
with potential substrates, the four purified BsTrxA
variants (wild type, C29S, C32S, and the double
mutant) were mixed with the cytoplasmic proteins,
incubated for 5min at room temperature, and
subsequently separated by SDS-PAGE under non-
reducing conditions. Next, the presence of stable
TrxA–substrate reaction intermediates, whichwouldperformed with the highly pure His6-tagged BsTrxAwith
nd cytoplasmic proteins from the TrxA-depleted B. subtilis
for mixed disulfide fishing were highly pure, 0.1 μg of each
trophoresis, the gel was silver-stained. WT, BsTrxA with
2S, C32S single-mutant BsTrxA; C29S–C33S, C29S–C32S
actions between BsTrxA and its substrates, 2 μg of each
protein extract. After 5 min of incubation, proteins were
exes were visualized by Western blotting, with antibodies
extract mock-treated with 2 μl of water instead of BsTrxA
rxA antibody. (c) Immunodetection of purified BsTrxA–
e bound complexes, the C-terminal His6-tag of the pure
a mutant active site was mixed with cytoplasmic protein
echarged with nickel were added, and the His6-tag of the
tic beads for 10 min. Amagnet was then used to collect the
ine times, the BsTrxA proteins were eluted from the beads
separated by nonreducing SDS-PAGE, and the BsTrxA–
ng with antibodies against BsTrxA.
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blotting using antibodies against BsTrxA. The results
of these interaction studies are shown in Fig. 1b. As
expected, it was found that the C32S BsTrxA, which
contains the attacking Cys29 residue, was able to
form stable interactions with potential substrate
proteins, whereas the C29S–C32S double mutant
did not form these interactions. This observation is
fully consistent with the known reaction mechanism
of thioredoxins and the anticipated accumulation of
enzyme–substrate complexes when the resolving
Cys32 is absent. In the experiment with the double-
mutant C29S–C32S, only a few bands of cytoplasmic
proteins that cross-reacted with the TrxA antibody
were detectable (Fig. 1b; compare lanes labeled
“background” and “C29S–C32S”). Similar to the re-
sults obtained with C32S BsTrxA, enzyme–substrate
complexes were identified when the wild-type TrxA
was incubated with potential substrates—consistent
with the fact that the catalytic site of this purified
protein is intact. Quite unexpectedly, however, we
observed that the C29S BsTrxA variant (lacking the
attacking Cys29 residue) was also able to form
reaction intermediates that could be separated by
SDS-PAGE, albeit with a slightly lower efficiency
than the C32S BsTrxA (Fig. 1b). Importantly, the
amount of reaction intermediates accumulating with
the C29S proteinwasmuch higher than that observed
for the wild-type BsTrxA protein (Fig. 1b). This
suggested that Cys32 can act as a nucleophile in
BsTrxA(C29S)–substrate interactions.
To further test the stability of the observed reaction
intermediates, we made use of the nickel-binding
property of the C-terminal His6-tag of the purified
BsTrxA proteins in an assay where binding to
magnetic beads precharged with nickel was ana-
lyzed. Upon incubation of purified wild-type or
mutant BsTrxA proteins with potential substrates
and these magnetic beads, the resulting substrate–
BsTrxA–beads complexes were extracted from the
reaction mixtures using a magnet. The results of
these “mixed disulfide fishing” experiments are de-
picted in Fig. 1c. This figure clearly shows that only
the mixed disulfides formed by the C32S BsTrxA
mutant protein were sufficiently stable for fishing. In
contrast, all reaction intermediates with the C29S
mutant or the wild-type BsTrxA protein were lost
during the washing of the beads (Fig. 1c), implying
that the respective interactions were significantly
less stable than those observed for the C32S mutant
and its potential substrates.
Notably, the interaction analyses indicated that all
purified TrxA proteins were capable of dimer form-
ation when analyzed under nonreducing conditions,
as evidenced by the presence of bands with twice the
mass of monomeric TrxA (Fig. 1b and c). Such
potential dimers were present when purified TrxA
proteins were mixed with potential substrates, and
they remained stable upon mixed disulfide fishing
with magnetic beads. Furthermore, the largest
amounts of potential dimers were detected for the
single-cysteine mutant proteins, the C32S mutant in
particular. By contrast, dimers of the double-cysteinemutant protein were barely detectable. Both the
finding that the C29Smutant proteinwas apparently
able to bind potential substrates and the observed
significant levels of dimerization of both single-
cysteine mutant BsTrxA proteins prompted us to
focus further attention on the properties of the single-
cysteine mutant BsTrxA proteins.
Redox state of BsTrxA
To study the properties of the C29S and C32S
single-mutant BsTrxA protein variants, the purified
His-tagged proteins were analyzed both by standard
SDS-PAGE and by capillary electrophoresis with a
2100 Bioanalyzer (Agilent Technologies) under
reducing and nonreducing conditions. The results
obtained in both approaches were highly compar-
able and, therefore, only the Bioanalyzer results are
shown in Fig. 2. Under nonreducing conditions, the
pure wild-type BsTrxA protein and the C29S–C32S
double-mutant protein showed an electrophoretic
mobility that was in accordance with the molecular
weight of BsTrxA (∼12 kDa). As already observed in
the mixed disulfide fishing experiments, the pure
C29S and C32S single-mutant proteins were sepa-
rated as two species under nonreducing conditions,
one of which migrated at∼12 kDa whereas the other
migrated at ∼25 kDa. As confirmed by Western
blotting using antibodies against BsTrxA, the∼25-kDa
band consisted of BsTrxA (not shown). Notably, the
relative abundance of the ∼25-kDa species was
higher for the C32S BsTrxA mutant protein (∼81%)
than for the C29S BsTrxA mutant protein (∼17%).
Furthermore, the band of ∼25 kDa was not observed
in the presence of the reducing agent DTT (Fig. 2a).
Together, these observations suggested that the
25-kDa band represents a BsTrxAdimer inwhich the
two identical subunits are held together by a bond
that can be broken with DTT. In order to estimate the
quantity of DTT required for the breakage of this
bond, the C32S BsTrxA protein was exposed to
increasing concentrations of DTT. As shown in
Fig. 2b, about 0.5 mM DTT was required for the
reduction of most C32S BsTrxA homodimers to
monomers, and about 0.15–0.2mMDTTwas required
to reduce 50% of these dimers. These observations
imply that the dimerization of the single-cysteine
mutant proteins was due to disulfide bond formation
between the active-site cysteine residues of two
monomers, firstly because Cys29 and Cys32 are the
only two-cysteine residues in BsTrxA and, secondly,
because no stable dimers were detectable for the
C29S–C32S double mutant (Fig. 2a). To verify this
idea, cross-linking experiments were performed with
the thiol-specific reagent 4-acetamido-4′-maleimidyl-
stilbene-2,2′-disulfonate (AMS). The binding of AMS
is known to result in a decreased electrophoretic
mobility of ∼0.5 kDa per bound AMS molecule,
allowing the separation of reduced and oxidized
proteins.34 As shown in Fig. 2a, AMS-treated wild-
type BsTrxA molecules migrated in two separate
bands of ∼12 and ∼13 kDa, representing oxidized
TrxA (lower band) and reduced BsTrxA with two
Fig. 2. Redox states of BsTrxA monomers and dimers. (a) Purified His6-tagged BsTrxA proteins were separated by
capillary electrophoresis using a 2100 Bioanalyzer (Agilent Technologies). WT, BsTrxAwith wild-type active site; C29S,
C29S single-mutant BsTrxA; C32S, C32S single-mutant BsTrxA; C29S–C32S, C29S–C32S double-mutant BsTrxA. To
monitor the presence of free thiols in the purified BsTrxA proteins, samples were incubated in the presence or in the
absence of 0.3 mM AMS (lanes marked +AMS or −AMS). To test whether the C29S and C32S dimers are formed by
disulfide bonding, these proteins were incubated with 10 mM DTT (lanes marked +DTT). DTTwas absent from all other
samples. The image of the Bioanalyzer chromatogram was generated using the 2100 Expert Software package (Agilent
Technologies). (b) C32S BsTrxA protein (∼2.5 μg) was reduced with increasing concentrations of DTT (shown on top of
the panel) and separated by capillary electrophoresis as described for (a). The dimer-to-monomer ratios (Dimer [%]) are
shown at the bottom of the panel.
524 Dimer Structure of C32S Mutant Bacillus TrxAbound AMSmolecules (upper band), respectively. By
peak integration, it was estimated that only about
33% of the wild-type BsTrxA was in a reduced state
under the conditions tested.As expected, the cysteine-
free C29S–C32S double-mutant BsTrxA protein did
not bind AMS (Fig. 2a). The monomeric C29S and
C32S single-mutant BsTrxA proteins treated with
AMSmigrated in a single band of∼12.5kDa (Fig. 2a),
indicating that all these single-cysteine mutant
BsTrxA molecules had bound one AMS molecule.
This showed that all single-cysteine mutant BsTrxA
monomerswere present in a reduced state. In contrast
to the ∼12-kDa species of the single-cysteine mutant
BsTrxA proteins, no AMS binding could be observed
for the∼25-kDa species of thesemutant proteins. This
showed that no free thiol groups are available in the
∼25-kDa species. In fact, the dimer of the C29S
mutant protein was resolved upon incubation with
AMS. Taken together, these findings strongly supportthe view that the ∼25-kDa species of the C29S and
C32S single-mutant BsTrxAproteins indeed represent
dimers of two identical BsTrxA subunits held together
by a disulfide bond.
BsTrxA homodimer structure
In order to verify the suggestion that the C32S
BsTrxA protein forms a homodimer linked together
via a disulfide bond between the attacking cysteines
in the identical subunits, we crystallized this protein
and subsequently determined its three-dimensional
structure to 1.5Å (Fig. 3a). The crystals belonged to
space group P1, with unit cell dimensions of a=
36.8Å, b=38.4Å, c=41.9Å, α=83.3°, β=66.6°, and
γ=78.1° (Table 1). Therewas one copy of the dimer in
the asymmetrical unit. The C32S BsTrxA homodimer
has the expected thioredoxin fold, with a central
hydrophobic core with a four-stranded β sheet sur-
Fig. 3. Overall fold and the dimer–interface interactions of the C32S BsTrxA dimer. (a) Overall fold of the C32S BsTrxA
dimer. The disulfide-bonded C32S BsTrxA chains are shown in yellow (chain A) and in blue (chain B). The C29–C29
disulfide bond between the chains is shown in orange. (b) Stereo diagram of the active site of the C32S BsTrxA dimer with
an electrostatic surface shown for chain A. The C32S active-site residues Trp28, Cys29, Gly30, and Pro31 are shown.
Carbon atoms are shown in yellow in chain A and in blue in chain B. Nitrogen and oxygen atoms are in dark blue and red,
respectively. The disulfide bond atoms are in orange, and hydrogen bonds are shown in green. (c) The shallow
hydrophobic binding sites for the Trp28 residues on the opposite chains of the dimer in the C32S mutant of BsTrxA. The
color coding is the same as in (b), and the view is an approximately 90° rotation relative to (b).
525Dimer Structure of C32S Mutant Bacillus TrxArounded by fiveα helices on the external surface (Fig.
3a). The C32S homodimer structure closely resem-
bles the NMR structure,12 with an rmsd of 0.9 Å bet-
ween 86 Cα carbon atoms (comparing the first model
of the 2IPA heterodimer BsTrxANMR structure with
chain A of the C32S BsTrxA structure). It is also
similar to the known human and E. coli structures
(PDB codes 2TRX, 1XOA, 1XOB, 1ERU, 1ERT, 1CQG,
1CQH, and 1MDJ) with rmsd values of 1–1.5Å
for global Cα superpositions. This underscores the
strong conservation of thioredoxin in nature. The
active-site amino acid sequence WCGPC forms a
loop linking the end of a β strand (β2) with the be-
ginning of an α helix (α2).Importantly, C32S TrxA does indeed crystallize as
a dimer held together by a disulfide bond between
the two active sites attacking Cys29 residues. In
addition, dimerization is facilitated by intermolecu-
lar hydrogen bonds and hydrophobic interactions.
Intermolecular hydrogen bonds occur between the
backbone amide nitrogen of Ile72 and the carbonyl
of Trp28, and between the backbone carbonyl of
Ile72 and the amide nitrogen of Gly30 (Fig. 3b). No
side chains are involved in intermolecular bonds in
this structure. The large hydrophobic residue Trp28,
which precedes the catalytic Cys29, interacts with a
shallow hydrophobic pocket on the other chain con-
sisting of the side chains of Ala26, Trp28, Val57,
Table 1. TrxA C32S data collection and refinement
statistics
Data processing
Beamline ESRF BM14
Wavelength (Å) 0.98
Space group P1
Unit cell
a, b, c (Å) 36.8, 38.4, 41.9
α, β, γ (°) 83.3, 66.6, 78.1
Resolution (Å) 50.0–1.5
Total observations 86,633
Unique reflections 31,147
Completeness (%) 94.5 (90.1)
Redundancy 2.8 (2.4)
I/σ(I) 15.6 (1.9)
Rsym (%) 7.0 (33.9)
Refinement
Resolution (Å) 23.0–1.5
R-factor (%) 18.5
Rfree (%) 23.7
rmsd from ideal values
Bond length (Å) 0.021
Bond angles (°) 2.027
Ramachandran plot
Most favored regions (%) 98.1
Additional allowed regions (%) 1.9
Generously allowed regions (%) 0.0
Disallowed regions (%) 0.0
Crystals were cryocooled directly into liquid nitrogen, and
diffraction data were collected at the ESRF beamline BM14.
Data were processed and refined as described in Materials and
Methods.
526 Dimer Structure of C32S Mutant Bacillus TrxAAla64, Val69, and Ile72 (Fig. 3c). In addition, the
backbone of residues Met70 and Ser71 packs against
the Trp28 ring (Fig. 3c). The chain B Trp28 has two
alternative conformations, whereas the chain A
Trp28 has only one orientation. In both chains, the
hydrophobic Trp28 interacts with the same surface
on the opposite chain. This series of hydrogen bonds
and hydrophobic interactions stabilizes the dimer
formation.
Comparison of the BsTrxA homodimer structure
and the TrxA–ArsC heterodimer structure showsthat although the fold of BsTrxA is very similar, its
binding mode is different (Fig. 4). Both structures
show extensive interactions with the catalytic loop
between Ala26 and Gly30. They both interact with
the loop and helix structure between Val57 and
Val69, although the BsTrxA–ArsC structure has a
much more extensive interaction. Only ArsC inter-
acts with the loop from residues Val88 to Lys91.
Whereas the BsTrxA homodimer uses the backbone
amide and carbonyl of Ile57 to form hydrogen bonds
to the other chain, the BsTrxA–ArsC structure does
not have these interactions. The two complexes
therefore show very different binding modes.
Comparison with thioredoxin complex
structures
Mixed disulfide intermediates of thioredoxin have
previously been characterized at the structural level
by NMR of human thioredoxin with two substrate
peptides derived from Ref-1 and nuclear factor κB
(NF-κB;14,15 PDB codes 1CQG, 1CQH, and 1MDJ),
by NMR of the BsTrxA–ArsC complex,12 and by X-
ray crystallography of barley thioredoxin complexed
with the substrate protein, BASI (HvTrxh2–BASI).16
In all these complex structures, the resolving cysteine
in thioredoxin was mutated to prevent the reaction
from proceeding, which would have caused the
complex to dissociate.
The structures of the thioredoxins in these com-
plexes were superimposed on chain A of the BsTrxA
homodimer structure, and the protein/peptide bin-
ding modes were compared (the thioredoxin com-
plex structures used in this study are listed in Table 2).
The directions of the polypeptide chain through the
thioredoxin active site are different in the NF-κB
peptide complex and in the Ref-1 peptide complex15
(Fig. 5a). In the BsTrxA–ArsC and HvTrxh2–BASI
complexes, the chain direction is similar to the Ref-1
peptide.16 The C32S BsTrxA homodimer structure
described here, however, has the same peptide chain
orientation as the NF-κB peptide (Fig. 5a). Interac-Fig. 4. Comparison of the B. sub-
tilis TrxA homodimer and BsTrxA–
ArsC complex structures. The B.
subtilis TrxA homodimer structure
is shown as a cartoon with chains A
and B in yellow and blue, respec-
tively. The disulfide bridge and the
Ser32 are shown in orange, as in
Fig. 3. The BsTrxA–ArsC complex
structure is shown in purple, with
the disulfide bridge and residue
Ser82 (from the C82S mutation in
ArsC) shown in red.
Table 2. Thioredoxin complex structures used in this study
PDB code
Thioredoxin
(mutation)
Trx catalytic residue:
substrate target residue
Other proteins in
complex (mutation) Method
Resolution
(Å) Reference
Thioredoxin–substrate complexes
1MDJ Human Trx (C35A,
C65A, C69A, C73A)
C32 : C62 Peptide consisting of residues 56–68
from the human substrate NF-κB
NMR N/A 14
1CQG Human Trx C32 : C65 Peptide consisting of residues 59–71 NMR N/A 15
1CQH (C35A, C65A, C69A,
C73A)
from the human substrate Ref-1
2IWT Barley HvTrxh2
(C49S)
C46 : C148 α-Amylase serine proteinase
inhibitor (BASI) (C144S)
X-ray 2.3 16
2IPA BsTrxA (C32S) C29 : C89 ArsC (C10S, C15A, C82S) NMR N/A 12
2VOC BsTrxA (C32S) C29 : C29 BsTrxA (C32S) homodimer X-ray 1.5 This study
Thioredoxin–thioredoxin reductase complexes
2PU9 Spinach chloroplast
(Trx-f) (C49S)
C46 : C57 Synechocystis ferrodoxin–thioredoxin
reductase
X-ray 1.65 20
2PUK Spinach chloroplast
(Trx-m) (C40S)
C37 : C57 Synechocystis ferrodoxin–thioredoxin
reductase
X-ray 3.0 20
1F6M E. coli TrxA (C35S) C32 : C138 E. coli thioredoxin reductase (C135S) X-ray 3.0 19
Other thioredoxin complexes
1T7P E. coli TrxA N/A Bacteriophage T7 DNA polymerase
and an DNA strand
X-ray 2.2 21
N/A, not available.
Structural data were retrieved from the PDB. The accession codes, relevant mutations, catalytic residues, interacting proteins, and
structure analysis details are summarized.
527Dimer Structure of C32S Mutant Bacillus TrxAtions between thioredoxin and its substrates usually
involve three loops from thioredoxin: the catalytic
loop (residues 31–35 in E. coli Trx) and two add-
itional binding loops (residues 74–76 and 91–93 in
the E. coli structure16). In the BsTrxA homodimer
structure described here, only two of these loops are
involved in the interactions; the third loop (residues
88–91) does not interact with the other chain of the
dimer.
In general, the complexes have large hydrophobic
residues on the substrate (either Trp, Tyr, orMet) that
interactwith a shallowhydrophobic groove: Trp28 in
the BsTrxA homodimer, Met91 in the BsTrxA–ArsC
heterodimer, Tyr67 in the Ref-1 peptide, Trp60 in the
NF-κB peptide, and Trp147 in the HvTrxh2–BASI
complex. In four of the structures (the two peptide
complexes, the C32S BsTrxA homodimer, and the
BsTrxA–ArsC structures), the hydrophobic interac-
tions occur in an equivalent part of the thioredoxin
surface (Fig. 5a). In contrast, the hydrophobic inter-
action between Trp147 in the BASI substrate and
HvTrxh2 occurs at a different site (Fig. 5a). In add-
ition, each complex is held together by four to five
intermolecular hydrogen bonds, although the details
of the individual interactions vary. The diversity of
the binding modes observed in these five complexes
illustrates how thioredoxin can bind to and react
with a variety of different substrates.
Thioredoxin also forms complexes with thioredoxin
reductase—the enzyme that converts oxidized thior-
edoxin back to the active reduced state. Structures of
complexes of E. coli thioredoxin with thioredoxin
reductase,19 and also chloroplast thioredoxins (Trx-m
and Trx-f) with Synechocystis ferredoxin–thioredoxin
reductase20 are available. These show completely
different thioredoxin-bindingmodes (Fig. 5b). The E.coli thioredoxin has relatively little contact between
the substrate peptide and the protein, although a
large hydrophobic residue of the thioredoxin reduc-
tase, Phe142, binds in approximately the same
position as the hydrophobic residues in the substrate
complexes (Fig. 5b). The Synechocystis ferredoxin–
thioredoxin reductase complexes have two loops
that bind at either end of the substrate-binding site
(Fig. 5b). The C32S BsTrxA homodimer complex is
therefore more closely related to the thioredoxin/
substrate complexes, in particular the NF-κB peptide
complex, rather than to the complexes with the
reductases.
The resolving cysteine
The original Cys32 residue in the wild-type
BsTrxA would resolve any intermolecular disulfide
bonds via its deprotonated sulfhydryl group in the
native enzyme. However, in this BsTrxA structure,
the C32S mutation is present. The Ser32 mutant is
unable to resolve the intermolecular disulfide or
form an intramolecular disulfide bond with Cys29.
The C32S mutation therefore ensures that the
reaction does not proceed along the reaction coordi-
nate. The crystal structure shows that the side chain
of the mutated residue C32S points away from the
intermolecular disulfide Cys29-Cys29 bond, forming
hydrogen bonds to the backbone amide of Ala26 and
the carbonyls of Ala26 or Cys29 (Fig. 6a). Similar
interactions would not be expected in the wild-type
Cys32, allowing the Cys32 side chain to rotate to an
alternative rotamer, which would be ideally posi-
tioned for attacking the intermolecular disulfide
bond intermediate. The Ser32 side chain is packed
between the side chains of Trp25, Pro31, and Ile72, so
Fig. 5. Comparison of protein/peptide binding modes in the BsTrxA C32S dimer and other thioredoxin peptide and
protein complexes. (a) BsTrxA was superimposed on the thioredoxin from other complexes using PyMOL.35 The
superimposed structures, the surface of chain A of BsTrxA, and the peptide or protein chain of the bound molecule are
shown. The disulfides and large hydrophobic residues that contribute to binding are also shown. The N- and C-termini of
the bound peptides and proteins are indicated with the letters N and C. The proteins shown in (a) are as follows: the
BsTrxA dimer with residues 26–38 of chain B shown as cartoons and the side chains of Trp28 and Cys29 shown as sticks
(this study; dark blue); the NMR structures of human thioredoxin complexed with substrate peptides from Ref-1 (1CQH;
red) or NF-κB (1MDJ; green) with the side chains of residues Cys65 and Tyr67 of the Ref-1 peptide and of residues Trp60
and Cys62 of the NF-κB peptide; the NMR structure of the B. subtilis TrxA and ArsC (2IPT; purple) with residues Cys89
and Met91; and the X-ray structure of the complex between barley thioredoxin and the α-amylase serine proteinase
inhibitor (2IWT; orange) with residues Trp147 and Cys148. (b) Comparison of the BsTrxA (dark blue) dimer interface with
the binding of thioredoxin reductase by E. coli thioredoxin (1F6M; yellow) and the X-ray structures of the complexes
between spinach chloroplast thioredoxins Trx-f and Trx-m and ferrodoxin–thioredoxin reductase (2PU9 and 2PUK; in
cyan and magenta, respectively). Trp28 is shown for the TrxA structure (dark blue), and the E. coli thioredoxin reductase
structure shows Phe142 (yellow).
528 Dimer Structure of C32S Mutant Bacillus TrxAit is buried inside the protein (Fig. 6b). A change of
the rotamer of Cys32 from that shown by Ser32
would allow the Cys32 side chain to attack the
disulfide bond in the wild-type enzyme. Even with a
change in rotamer, Cys32 would not be exposed at
the protein surface to the same extent as Cys29. In
order for Cys32 to act as the reactive cysteine in the
C29S mutant, a change in the conformation of the
catalytic loop may be necessary, so that Cys32 could
be available on the protein surface to react with
substrate proteins.
Taken together, our present structural analysis of
the C32S BsTrxA dimer indicates that the high-reso-
lution structure obtained in this study can serve to
visualize a mixed disulfide intermediate state in thethiol–disulfide exchange reaction catalyzed by the
native enzyme.Discussion
In the present study, we characterized active-site
mutants of TrxA from B. subtilis at the molecular and
structural levels. To this end, we highly purified
three active-site mutants and the wild-type BsTrxA
protein. Mixed disulfide reaction intermediates
could be generated, in particular between the C32S
BsTrxA and its substrates, but alsowith the C29S and
wild-type BsTrxA. The analyses on our purified
BsTrxA proteins revealed that the single-cysteine
Fig. 6. Ser32 interactions in the BsTrxA C32S structure. (a) The loop from residue 26–32 in chain A of the BsTrxA C32
structure is shown with the hydrogen bonds to the Ser32 residue. C29 from chain B is also shown, and the disulfide bond
is shown in orange. Oxygen and nitrogen atoms are in red and blue, respectively. The carbon atoms of chains A and B are
in blue and yellow, respectively. Hydrogen bonds are shown in green. (b) The environment surrounding S32 is shown.
The catalytic loops with residues 25–33 and 72 are shown as sticks, and other parts of the structure are shown as cartoons.
The colors are the same as in (a).
529Dimer Structure of C32S Mutant Bacillus TrxAactive-site mutant BsTrxA proteins not only bound
substrates but also had a high tendency to bind to
each other. Specifically, the pure single-cysteine
BsTrxA mutant proteins displayed auto-oxidation
of the remaining active-site cysteine residues, which
resulted in homodimer formation. We were able to
confirm this stable interaction by characterizing the
structure of the C32S BsTrxA homodimer at 1.5Å
resolution. The structure obtained is unique in that it
is the first structure of an active-site cross-linked
thioredoxin homodimer that could be regarded as a
stable mixed disulfide BsTrxA reaction intermediate.
The structure also represents the first example of a
thioredoxin protein–protein complex with a chain
orientation similar to that of the peptide from NF-κB
(Fig. 5a). A common theme observed in all but one of
the thioredoxin protein and peptide complexes is an
interaction between a shallow hydrophobic groove
on the surface of the thioredoxin protein adjacent to
the disulphide and a large hydrophobic residue from
the binding partner. One complex, the HvTrxh2–
BASI complex, lacks this interaction but instead has a
site on the other side of the disulphide where a hy-drophobic residue is found. These structures there-
fore illustrate alterative thioredoxin/substrate bin-
ding modes.
Our present study shows that both the C32S
BsTrxAmutant protein and the C29S BsTrxAmutant
protein are able to form mixed disulfide intermedi-
ates when provided with potential substrate pro-
teins. To our knowledge, the finding that BsTrxA
mutant proteins lacking the attacking cysteine resi-
due can form such intermediates has not been re-
ported before. In fact, most documented interaction
profiling studies, based on the mixed disulfide fish-
ing technique, were only performed with a mutated
variant lacking the resolving cysteine residue (Cys32
in BsTrxA), but not with mutant forms lacking the
attacking cysteine residue (Cys29 in BsTrxA).29,36,37
According to the generally accepted model for
thioredoxin function, the Cys29 appears as a thiolate,
whereas Cys32 is kept protonated.9,10,38,39 Our data
suggest that the resolving cysteine in the C29S
mutant protein is also able to engage in substrate
binding. Studies on E. coli Trx1 have shown that the
unusually low pKa of the attacking cysteine is main-
530 Dimer Structure of C32S Mutant Bacillus TrxAtained by proton sharing of the thiol proton, which is
normally attached to the resolving cysteine, thereby
giving the resolving cysteine a high pKa.
40,41 Muta-
tion of the attacking cysteine in the C29S proteinmay
therefore result in a lower pKa of the resolving cys-
teine, giving it a higher reactivity towards possible
substrates than in the wild-type protein. Our mixed
disulfide experiments indicate that Cys29 is more
effective in forming stable reaction intermediates
with potential substrate proteins than Cys32. In the
available BsTrxA C32S mutant structure, the Ser32
side chain is not exposed on the protein surface
(Fig. 6b); it is oriented away from the intramolecular
disulfide bond and forms a series of hydrogen bonds
(Fig. 6a). Thewild-type Cys32would not be expected
to form similar hydrogen bonds and may therefore
adopt a different position.12,40 Rotation of the
side chain would allow Cys32 to attack the disulfide
bond and complete the reaction. However, a further
change in the structure may be required to expose
Cys32 on the protein surface, so that it can react with
substrate proteins. This change in conformation
could perhaps be caused by the C29S mutation,
since the serine side chain could form extra interac-
tions that could assist in modifying the structure.
This would explain why the C29S mutant BsTrxA
does not react as efficiently with substrate proteins
relative to the C32S mutant protein. To confirm
or falsify this speculation, we would need a high-
resolution structure of C29Smutant BsTrxA, which is
presently not available.
A second interesting result of the present study
was the homodimerization of single-cysteine BsTrxA
mutant proteins by thiol oxidation. It should be
noted that auto-oxidation of E. coli thioredoxin has
beenmentioned in the literature for amutant protein
lacking the resolving cysteine,32,33 but not for a
mutant protein lacking the attacking cysteine. Other
thioredoxin dimers were shown to be formed by
thiol (auto)oxidation of a third cysteine residue out-
side the active site (e.g., Cys73 of human Trx1).13 This
Cys73-based dimerization is believed to function as a
means to down-regulate thioredoxin activity, since
such dimerswere found to be inactive.42 Notably, the
only two-cysteine residues of BsTrxA are the active-
site cysteine residues, precluding the possibility of
the regulation of thioredoxin activity via oxidation–
reduction of a third cysteine residue. Thus, the ob-
served dimerization of the single-cysteine mutant
TrxA proteins is unrelated to the regulatory Trx1
dimerization. In addition, dimer formation under
reducing acidic conditions via noncovalent binding
has been reported for E. coli and human thioredo-
xins.43–46 Such thiol-independent dimerization was
not observed for the purified BsTrxA. Furthermore, it
should be noted that mutants of E. coli TrxAwith an
altered active site (CACA instead of CGPC) were
also shown to dimerize via active-site cysteine resi-
dues.47 In this case, however, the dimerization was
due to the fact that the mutation changed the E. coli
TrxA conformation such that the second cysteine
residue of the CACAmotif became surface-exposed.
Moreover, in this dimer structure, both cysteine re-sidues in the CACA motif were disulfide-bonded.
This makes the E. coli CACA TrxA dimer quite
distinct from the C32S BsTrxA dimer reported here.
Altogether, we conclude that the reported dimeri-
zation of both single-cysteine active-site mutant
BsTrxA proteins by thiol oxidation of the remaining
cysteine residues differs substantially from most
previously reported mechanisms for thioredoxin
dimerization.
It is presently not known whether BsTrxA mole-
cules interact with each other in vivo, but this possi-
bility seems likely because both oxidized and re-
duced forms of BsTrxA can be detected in growing
cells.48 In any case, the mixed disulfide homodimers
of single-cysteine mutant BsTrxA provide an inter-
esting opportunity to study the three-dimensional
topology of the normally very short-lived mixed di-
sulfide reaction intermediate state between two pro-
teins taking part in a thiol–disulfide exchange react-
ion. In the structure of the oxidized C32S BsTrxA
mutant dimer, one BsTrxA moiety would represent
the enzyme, and the other one would represent the
substrate. The structural studies of the human Trx1,
in complex with two distinct substrate peptides,
showed that the peptides bind in opposite orient-
ations.14,15 The structure of C32S BsTrxA described
here adopts one of these orientations (that of the NF-
κB peptide), whereas the thioredoxin/substrate
protein complex HvTrxh2–BASI16 and the BsTrxA–
ArsC complex12 adopt the alternative Ref-1 peptide
orientation. The C32S BsTrxA structure therefore
represents a different mode by which thioredoxin
can bind substrate proteins, demonstrating the exist-
ence of the binding mode shown with the NF-κB
peptide. The binding of substrate protein is stabi-
lized by hydrogen bonds and hydrophobic interac-
tions between a large hydrophobic group on the
binding partner and hydrophobic patches on the
surface of thioredoxin (Figs. 3, 5 and 6). The C32S
BsTrxA structure, in comparisonwith other disulfide
intermediate structures, therefore illustrates how
thioredoxin accommodates a variety of substrates
using alternative hydrogen bonding patterns and
more than one possible hydrophobic region.
Since the identified C32S BsTrxA homodimer is
formed by thiol oxidation between two identical
BsTrxA molecules, this implies that these intrinsi-
cally reductive molecules undergo auto-oxidation.
This is probably due to the fact that our interaction
studies were performed in vitro under nonreducing
conditions. Exposure of the purified proteins to oxi-
dative compounds, such as molecular oxygen, is
likely to result in their oxidation. Consistent with this
idea, we demonstrated via cross-linking of AMS to
free thiols thatmost of the purifiedwild-type BsTrxA
molecules were in fact oxidized under the conditions
used. Thus, the redox state of wild-type BsTrxA
in vitro may, to some extent, resemble the in vivo
redox state of this protein.48
In conclusion, during the establishment of the ne-
cessary tools for mixed disulfide fishing in B. subtilis,
we discovered that purified single-cysteine BsTrxA
mutant proteins are subject to auto-oxidation, for-
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ing cysteine residues. The structure of a C32S homo-
dimer of BsTrxA was solved at high resolution,
which provides interesting and novel insights into
the BsTrxA active-site geometry during the covalent
substrate-bound intermediate state of catalysis. The
structure demonstrates a binding mode, which, in
comparison with other mixed disulfide intermediate
structures, illustrates how thioredoxin can bind to
and react with a variety of different substrates.Materials and Methods
Growth conditions and media
Strains were grown with constant agitation (250rpm) at
37 °C in Luria–Bertani medium consisting of 1% tryptone,
0.5% yeast extract, and 1% NaCl (pH7.4). When appro-
priate, media were supplemented with antibiotics at the
following concentrations: chloramphenicol, 5 μg/ml;
kanamycin, 50 μg/ml; erythromycin, 2 μg/ml.
Cloning, expression, and purification of BsTrxA
All procedures for DNA purification, restriction, liga-
tion, agarose gel electrophoresis, and transformation of
competent E. coliDH5α cellswere carried out as previously
described.49 Chromosomal DNA of B. subtilis 168 (trpC2)50
was isolated according to Bron and Venema, and plasmid
DNAwas isolated using the High Pure Plasmid Isolation
Kit (Roche Applied Science).51 The trxA gene from B.
subtilis 168was PCR-amplified using the primers GGGGG-
CATATGGCTATCGTAAAAGCAACTGA and GGGGGC-
TCGAGAAGATGTTTGTTTACAAGCT. The PCR product
was ligated into the NdeI and XhoI restriction sites of the
pET-26b(+) expression vector (Novagen, Inc.). The resulting
pET26-trxA plasmidwas subsequently used for site-directed
mutagenesis by plasmid PCR with the Extensor PCR mix
(ABgene) to obtain mutant trxA genes in which codons for
Cys were replaced with codons for Ser. Primers C29S-F
(GCTCCTTGGTCCGGACCTTGT) and C29S-R (ACAAG-
GTCCGGACCAAGGAGC) were used to introduce the
C29Smutation in BsTrxA; primers C32S-F (TGCGGACCT-
TCTAAAATGATT) and C32S-R (AATCATTTTAGAAGG-
TCCGCA) were used to introduce the C32S mutation in
BsTrxA; and primers C29S/C32S-F (CCTTGGTCCGGAC-
CTTCTAAAATG) and C29S/C32S-R (CATTTTAGAAG-
GTCCGGACCAAGG) were used to introduce the C29S–
C32S doublemutation inBsTrxA.All constructswere checked
by sequencing. The generated pET26b plasmids were used
to transform E. coli BL21(DE3) (Invitrogen) for high-level
trxA expression and subsequent purification of the wild-
type BsTrxA or the different Cys-to-Ser mutant variants of
this protein. Notably, all BsTrxA proteins used in the
present study contain a C-terminal hexa-histidine His6-tag
for purification purposes. This tag is provided by the
pET26b(+) vector. For BsTrxA purification, 1-L cultures
were grown until an OD600 of 0.7 had been reached. Then,
IPTGwas added to a final concentration of 1mM to induce
BsTrxA production. After 3h of induction, cells were har-
vested by centrifugation and resuspended in binding
buffer [20mMNaPi, 300mMNaCl, 10% (vol/vol) glycerol,
5 mM imidazole, and 3mMDTT (pH7.4)]. Next, cells were
disrupted by two passages through a French Press
(2500 psi). Cellular debris was removed by centrifugation(30 min at 30,000g and 4 °C), and the clarified supernatant
fraction was applied to a nickel-charged IMAC column
(5 ml of HisTrap HP; GE Healthcare). Unbound sample
was washed from the column with binding buffer using
an ÄKTA explorer (GE Healthcare). Next, the His-tagged
BsTrxA protein was eluted from the column using binding
buffer with a gradient of increasing imidazole concentra-
tions (up to 500 mM imidazole). The eluted fractions were
checked for the presence of pure BsTrxA protein using SDS-
PAGE and subsequent silver staining or Western bloting.
Further purification was achieved by concentrating the
proteins with Vivaspin columns (Vivascience) and loading
them on a Superdex 75 gel filtration column (Amersham)
preequilibrated with 20 mM NaPi, 150mM NaCl, 10%
glycerol, and 3.5 mMDTT (pH7.4). Fractions containing the
purified BsTrxA proteins were pooled and dialyzed three
times against 20 mM Tris–HCl (pH7.6) with 150 mMNaCl.
B. subtilis total cytoplasmic proteins
Cytoplasmic proteins were extracted from B. subtilis
strainWB800 ItrxA (trpC2, nprE, aprE, epr, vpr, bpr,mpr∷ble,
nprB∷bsr, wprA∷hyg; trxA∷pMutin2; CmR, EmR). This
strain is based on B. subtilis WB800, which lacks eight
extracellular proteases,52 and it contains a trxA gene placed
under the transcriptional control of the Pspac promoter.23,24
Thus, protein degradation during the preparation of ex-
tracts is minimized and, at the same time, the oxidation of
TrxA substrates can be optimized through TrxA depletion.
Depletion of TrxA was achieved by growing cells in the
presence of 25 μM IPTG.24 Cells were harvested from an
exponentially growing 1-L culture (OD600 = 1.0) and resus-
pended in 10 ml of protoplast buffer [20 mM potassium
phosphate (pH7.5), 15 mMMgCl2, and 20% sucrose]. Next,
cells were incubated with Complete protease inhibitors at
the concentration recommended by the supplier (Roche
Applied Science) and 1 mg/ml lysozyme for 30 min at
37 °C, after which the protoplasts were disrupted using a
French Press (2500 psi). Cellular debris and the large mem-
brane fraction were removed by centrifugation (30 min,
150,000g, 4 °C), and the supernatant fraction containing the
cytoplasmic proteins was aliquoted and stored at − 80 °C.
SDS-PAGE and Western blotting
The presence of TrxAwas detected by Western blotting.
Proteins were separated by SDS-PAGE (using precast
NuPAGE gels from Invitrogen), and proteins were then
semi-dry-blotted (75 min at 1 mA/cm2) onto a nitrocellu-
lose membrane (Protran®; Schleicher and Schuell). Subse-
quently, the TrxA proteins were detected with polyclonal
antibodies raised against BsTrxA in rabbits (Eurogentec).
The detection of bound antibodies was performed with
either horseradish-peroxidase-conjugated IgG secondary
antibodies and the Super Signal® West Dura Extended
Duration Substrate (Pierce) in combination with the Che-
miGenius XE Bio-Imaging system (Syngene), or fluores-
cent IgG secondary antibodies (IRDye 800 CW goat anti-
rabbit from LiCor Biosciences) in combination with the
Odyssey Infrared Imaging System (LiCor Biosciences). In
the latter case, fluorescence at 800 nm was recorded. In
addition, protein 50 assay chips, together with the 2100
Bioanalyzer (Agilent Technologies), were used to analyze
the proteins. This lab-on-a-chip system allows the separa-
tion of proteins by capillary gel electrophoresis. The re-
corded chromatograms can be converted in silico to images
that resemble the results of SDS-PAGE. The peak surfaces
of the recorded chromatograms were integrated using the
532 Dimer Structure of C32S Mutant Bacillus TrxA2100 Expert Software (Agilent Technologies) to quantify
the relative protein amounts per peak.
Mixed disulfide fishing
To visualize possible stable interactions between BsTrxA
and its substrates, 2 μg of the purified BsTrxA protein
variants was mixed with 50 μl of total cytoplasmic protein
extract. After 5 min of incubation at room temperature,
protein loading buffer was added, and 3 μl of this sample
was loaded on a nonreducing gel, and TrxA–substrate-
bound proteins were visualized by Western blotting with
anti-BsTrxA antibodies.
For purification of the BsTrxA–substrate bound com-
plexes, 40 μg of each purified BsTrxA protein variant was
mixed with 250 μl of total cytoplasmic protein extract and
left to incubate on ice for 5 min. Next, 30 μl of magnetic
beads precharged with nickel (supplied by Zebra
Biosciences) was added. The His6-tagged BsTrxA pro-
teins were allowed to bind to the nickel of the magnetic
beads for 10min under constant inversion of the tubes.
Then, the tubes were placed in a magnetic field until
clearing of supernatant had been observed. The clear
supernatant was discarded from each tube, and the pellet
was washed three times (10 min) with 300 μl of binding
buffer [20 mM Tris–HCl (pH7.5) and 300 mM NaCl]
under constant tube inversion. Next, the BsTrxA proteins
bound to the magnetic beads were washed six times with
400 μl of washing buffer (i.e., binding buffer with 5 mM
imidazole). Finally, the tagged BsTrxA proteins with
bound potential substrates were separated from the
nickel-charged magnetic beads by resuspension in 150 μl
of elution buffer (i.e., binding buffer with 300 mM
imidazole). The eluted proteins were separated by
nonreducing SDS-PAGE, and the presence of TrxA–
substrate complexes was visualized by Western blotting
with anti-TrxA antibodies.
Determination of redox states of TrxA monomers and
dimers
The purified His6-tagged BsTrxA proteins with wild-
type or mutant active sites were analyzed by SDS-PAGE
under reducing and nonreducing conditions using pre-
cast NuPAGE gels (Invitrogen). Each lane was loaded
with ∼2.5 μg of protein. For analysis of BsTrxA proteins
under reducing conditions, 10mM DTT was added to the
samples prior to SDS-PAGE. In addition, the C32S BsTrxA
was analyzed in the presence of increasing concentrations
of DTT. Upon electrophoresis, protein bands were stained
with Coomassie SimplyBlue™ SafeStain (Invitrogen). The
redox state of the purified proteins was monitored by la-
belingwith AMS (Molecular Probes) prior to separation by
SDS-PAGE under nonreducing conditions. Notably, AMS
will only bind covalently to free thiol groups in reduced
BsTrxA molecules, thereby giving the reduced proteins a
mass higher than that of the oxidized ones. To quantify the
levels of AMS labeling, as well as dimer-to-monomer
ratios, the wild-type and mutant BsTrxA proteins were
also separated with protein 50 assay chips on a 2100 Bio-
analyzer (Agilent Technologies).
Crystallization
For crystallization, purified proteinwas buffer-exchanged
into a solution containing 25mMsodiumphosphate (pH8.0)
and 400mMNaCl and concentrated to 10mg/ml. Hanging-drop crystallization experiments were performed with 1 μl
each of protein and well solution using 24-well Linbro
plates stored at 4 °C. The crystallization solutions and the
temperature choice were based on the published condi-
tions used to crystallize TrxA from E. coli: 0.1 M Tris
(pH8.5), 0.2 M magnesium chloride, 4% acetonitrile, and
30% polyethylene glycol 4000.47 Crystals of the C32S single
mutant grew in 0.1 M Tris (pH7.8), 0.1 M magnesium
chloride, 4% acetonitrile, and 35% polyethylene glycol
4000. The crystals appeared in 1–2weeks with dimensions
of approximately 100 μm×50 μm×20 μm.
Data collection and structure determination
Crystals were cryocooled directly into liquid nitrogen,
and diffraction data were collected at the European Syn-
chrotron Radiation Facility (ESRF) beamline BM14. Data
collection statistics are summarized in Table 1. The data
were scaled and processed using the program HKL2000.53
Molecular replacement was performed using the program
PHASER54 in the CCP4 program suite, with a polyserine
model of TrxA from E. coli (PDB code 2TRX) as the initial
model.18 After a round of rigid-body and restrained re-
finement using REFMAC555 from the CCP4 program suite,
the model-building program ARP-WARP56 was used to
build a starting model from the BsTrxA C32S sequence.
The model was improved by several rounds of model
building and refinement, using the programs Coot57 and
REFMAC5.Model geometry was analyzed using Coot and
the program MolProbity.58 The two Pro31 side chains in
the two chains of the homodimer are only 2.6 Å apart in the
current model. This provides the best fit to the electron
density. This clash would not normally occur in the wild-
type enzyme. It is likely that the twoproline residues adopt
alternative nonclashing positions in solution, but these are
not apparent in the averaged electron density map and so
they are not included in themodel. Figures were generated
using the program PyMOL.35 Structures were super-
imposed using the align command in PyMOL.35
Accession numbers
Coordinates and structure factors have been deposited
in the PDB with accession number 2VOC.Acknowledgements
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